Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Romiplostim: an alternative treatment option besides rituximab for the management of steroid refractory idiopathic thrombocytopenic purpura.

× No keyword cloud information.

4 in total

1. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

Authors: James B Bussel; David J Kuter; James N George; Robert McMillan; Louis M Aledort; George T Conklin; Alan E Lichtin; Roger M Lyons; Jorge Nieva; Jeffrey S Wasser; Israel Wiznitzer; Reggie Kelly; Chien-Feng Chen; Janet L Nichol
Journal: N Engl J Med Date: 2006-10-19 Impact factor: 91.245

2. An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura.

Authors: Adrian Newland; Marie T Caulier; Mies Kappers-Klunne; Martin R Schipperus; Francois Lefrere; Jaap J Zwaginga; Jenny Christal; Chien-Feng Chen; Janet L Nichol
Journal: Br J Haematol Date: 2006-11 Impact factor: 6.998

3. The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura.

Authors: Semir Pasa; Abdullah Altintas; Timucin Cil; Ramazan Danis; Orhan Ayyildiz
Journal: J Thromb Thrombolysis Date: 2008-03-03 Impact factor: 2.300

4. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Authors: David J Kuter; James B Bussel; Roger M Lyons; Vinod Pullarkat; Terry B Gernsheimer; Francis M Senecal; Louis M Aledort; James N George; Craig M Kessler; Miguel A Sanz; Howard A Liebman; Frank T Slovick; J Th M de Wolf; Emmanuelle Bourgeois; Troy H Guthrie; Adrian Newland; Jeffrey S Wasser; Solomon I Hamburg; Carlos Grande; François Lefrère; Alan Eli Lichtin; Michael D Tarantino; Howard R Terebelo; Jean-François Viallard; Francis J Cuevas; Ronald S Go; David H Henry; Robert L Redner; Lawrence Rice; Martin R Schipperus; D Matthew Guo; Janet L Nichol
Journal: Lancet Date: 2008-02-02 Impact factor: 79.321

4 in total